Viewing Study NCT03953092


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-25 @ 6:08 PM
Study NCT ID: NCT03953092
Status: COMPLETED
Last Update Posted: 2021-01-11
First Post: 2019-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699
Sponsor: Youngene Therapeutics Inc., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-05-01
Start Date Type: ACTUAL
Primary Completion Date: 2019-11-13
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-13
Completion Date Type: ACTUAL
First Submit Date: 2019-05-14
First Submit QC Date: None
Study First Post Date: 2019-05-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-07
Last Update Post Date: 2021-01-11
Last Update Post Date Type: ACTUAL